GALDERMA GROUP AG (GDERF)
- Previous Close
0.00 - Open
82.00 - Bid 114.00 x 45100
- Ask 124.85 x 21500
- Day's Range
82.00 - 82.00 - 52 Week Range
77.72 - 120.00 - Volume
150 - Avg. Volume
242 - Market Cap (intraday)
28.49B - Beta (5Y Monthly) --
- PE Ratio (TTM)
123.72 - EPS (TTM)
0.97 - Earnings Date Jul 24, 2025
- Forward Dividend & Yield 0.18 (0.15%)
- Ex-Dividend Date Apr 25, 2025
- 1y Target Est
--
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services that span the spectrum of the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Dysport/Azzalure, Alluzience, Restylane, and Sculptra in injectable aesthetics; Cetaphil and Alastin in dermatological skincare; and Soolantra, Epiduo, Differin, Aklief, Epsolay, Twyneo, Oracea, Metvix, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
www.galderma.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: GDERF
View MorePerformance Overview: GDERF
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GDERF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GDERF
View MoreValuation Measures
Market Cap
28.46B
Enterprise Value
30.76B
Trailing P/E
123.72
Forward P/E
44.25
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.43
Price/Book (mrq)
3.66
Enterprise Value/Revenue
6.93
Enterprise Value/EBITDA
32.08
Financial Highlights
Profitability and Income Statement
Profit Margin
5.20%
Return on Assets (ttm)
3.34%
Return on Equity (ttm)
3.51%
Revenue (ttm)
4.44B
Net Income Avi to Common (ttm)
231M
Diluted EPS (ttm)
0.97
Balance Sheet and Cash Flow
Total Cash (mrq)
457M
Total Debt/Equity (mrq)
35.42%
Levered Free Cash Flow (ttm)
131.38M